Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
Diagnosis in subdural myeloid sarcoma
Lackey A, Laing B, Perkins A, Bryant M
(2017), Neuroradiol J, 30(3), 269-73
Resveratrol mitigates trophoblast and endothelial dysfunction partly via activation of nuclear factor erythroid 2-related factor-2
Gurusinghe S, Cox AG, Rahman R, Chan ST, Muljadi R, Singh H, Leaw B, Mockler JC, Marshall SA, Murthi P, Lim R, Wallace EM
(2017), Placenta, 60, 74-85
The Snail Family in Normal and Malignant Haematopoiesis
Carmichael CL, Haigh JJ
(2017), Cells Tissues Organs, 203(2), 82-98
DOI: 10.1159/000448655
Grainyhead-like 3 (Grhl3) deficiency in brain leads to altered locomotor activity and decreased anxiety-like behaviors in aged mice
Dworkin S, Auden A, Partridge DD, Daglas M, Medcalf RL, Mantamadiotis T, Georgy SR, Darido C, Jane SM, Ting SB
(2017), Dev Neurobiol, 77(6), 775-88
DOI: 10.1002/dneu.22469
Did He Who Made the Lamb Make Thee? New Developments in Treating the Fearful Symmetry of Acute Myeloid Leukemia
Brumatti G, Lalaoui N, Wei AH, Silke J
(2017), Trends Mol Med, 23(3), 264-281
Myeloma in the real world: what is really happening?
Bergin K, McQuilten Z, Moore E, Wood E, Spencer A
(2017), Clin Lymphoma Myeloma Leuk, 17(3), 133-44.e1
The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia
Tan P, Tiong IS, Fleming S, Pomilio G, Cummings N, Droogleever M, McManus J, Schwarer A, Catalano J, Patil S, Avery S, Spencer A, Wei A
(2017), Oncotarget, 8(32), 52269-80
Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia
Kantarjian H, Stein A, Gàkbuget N, Fielding AK, Schuh AC, Ribera JM, Wei A, Dombret H, Foá R, Bassan R, Arslan Ö, Sanz MA, Bergeron J, Demirkan F, Lech-Maranda E, Rambaldi A, Thomas X, Horst HA, Br?ggemann M, Klapper W, Wood BL, Fleishman A, Nagorsen D, Holland C, Zimmerman Z, Topp MS
(2017), N Engl J Med, 376(9), 836-47
Metabolic gatekeeper function of B-lymphoid transcription factors
Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, Shojaee S, Cazzaniga V, Schjerven H, Ernst T, Hochhaus A, Kornblau SM, Konopleva M, Pufall MA, Cazzaniga G, Liu GJ, Milne TA, Koeffler HP, Ross TS, S?nchez-GarcÃa I, Borkhardt A, Yamamoto KR, Dickins RA, Graeber TG, M?schen M
(2017), Nature, 542(7642), 479-83
DOI: 10.1038/nature21076
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia
Bradstock KF, Link E, Di Iulio J, Szer J, Marlton P, Wei AH, Enno A, Schwarer A, Lewis ID, D'Rozario J, Coyle L, Cull G, Campbell P, Leahy MF, Hahn U, Cannell P, Tiley C, Lowenthal RM, Moore J, Cartwright K, Cunningham I, Taper J, Grigg A, Roberts AW, Benson W, Hertzberg M, Deveridge S, Rowlings P, Mills AK, Gill D, Bardy P, Campbell L, Seymour JF; Australasian Leukaemia & Lymphoma Group
(2017), J Clin Oncol, 35(15), 1678-85
Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma
Mithraprabhu S, Khong T, Ramachandran M, Chow A, Klarica D, Mai L, Walsh S, Broemeling D, Marziali A, Wiggin M, Hocking J, Kalff A, Durie B, Spencer A
(2017), Leukemia, 31(8), 1695-705
DOI: 10.1038/leu.2016.366
Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia
Fleming S, Ong DM, Jackson K, Avery S, Mollee P, Marlton P, Kennedy G, Wei AH
(2017), Br J Haematol, 177(2), 328-30
DOI: 10.1111/bjh.14063
Genomic characterisation of EΜ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene
Lefebure M, Tothill RW, Kruse E, Hawkins ED, Shortt J, Matthews GM, Gregory GP, Martin BP, Kelly MJ, Todorovski I, Doyle MA, Lupat R, Li J, Schroeder J, Wall M, Craig S, Poortinga G, Cameron D, Bywater M, Kats L, Gearhart MD, Bardwell VJ, Dickins RA, Hannan RD, Papenfuss AT, Johnstone RW
(2017), Nat Commun, 8, 14581
DOI: 10.1038/ncomms14581
Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome
Witkowski MT, Hu Y, Roberts KG, Boer JM, McKenzie MD, Liu GJ, Le Grice OD, Tremblay CS, Ghisi M, Willson TA, Horstmann MA, Aifantis I, Cimmino L, Frietze S, den Boer ML, Mullighan CG, Smyth GK, Dickins RA
(2017), J Exp Med, 214(3), 773-9
DOI: 10.1084/jem.20160048
Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency
Ginn SL, Hallwirth CV, Liao SH, Teber ET, Arthur JW, Wu J, Lee HC, Tay SS, Hu M, Reddel RR, McCormack MP, Thrasher AJ, Cavazzana M, Alexander SI, Alexander IE
(2017), Mol Ther Nucleic Acids, 6, 1-14
A flowcytometric analysis to efficiently quantify multiple innate immune cells and T Cell subsets in human blood
Draxler DF, Madondo MT, Hanafi G, Plebanski M, Medcalf RL
(2017), Cytom Part A, 91(4), 336-50
DOI: 10.1002/cyto.a.23080
Significant age, race and gender differences in global coagulation assays parameters in the normal population
Ho P, Ng C, Rigano J, Tacey M, Smith C, Donnan G, Nandurkar H
(2017), Thromb Res, 154, 80-3
High rates of potentially infectious exposures between immunocompromised patients and their companion animals: an unmet need for education. Gurry GA, Campion V, Premawardena C, Woolley I, Shortt J, Bowden DK, Kaplan Z, Dendle C
Gurry GA, Campion V, Premawardena C, Woolley I, Shortt J, Bowden DK, Kaplan Z, Dendle C
(2017), Intern Med J, 7(3), 333-5
DOI: 10.1111/imj.13361
Specification of neurotransmitter identity by Tal1 in thalamic nuclei
Lee B, Lee M, Song S, Loi LD, Lam DT, Yoon J, Baek K, Curtis DJ, Jeong Y
(2017), Dev Dyn, 246(10), 749-58
DOI: 10.1002/dvdy.24546
Fibrinolysis: Biochemistry, Clinical Aspects, and Therapeutic Potential
Kwaan H, Lisman T, Medcalf RL
(2017), Semin Thromb Hemost, 43(2), 113-4